Nanoparticle 'Bomb' tested to boost cancer treatment
NCT ID NCT04862455
Summary
This study tested a three-part treatment for advanced head and neck cancer that has come back or spread. Doctors injected a nanoparticle called NBTXR3 directly into a tumor, then activated it with a short, precise course of radiation. Patients also received the immunotherapy drug pembrolizumab, aiming to help the immune system attack the cancer. The goal was to see if this combination could better control the disease in patients who had limited response to standard immunotherapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.